Valuation: Optimax Holdings

Market Cap 285M 70.08M 61.33M 56.52M 52.39M 99.45M 6.65B 101M 678M 264M 3.28B 263M 257M 11.35B P/E 2026 *
18.4x
P/E 2027 * 16.3x
Enterprise Value 282M 69.32M 60.66M 55.91M 51.82M 98.37M 6.58B 99.95M 670M 261M 3.25B 260M 255M 11.22B EV / Sales 2026 *
1.86x
EV / Sales 2027 * 1.73x
Free-Float
23.9%
Yield 2026 *
3.01%
Yield 2027 * 3.5%
05-25 Maybank Research Downgrades Optimax Holdings to Hold from Buy; Price Target is MYR0.58 MT
05-22 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-03 Optimax to Start Offering ENT Services Following Malaysian Health Ministry's Nod MT
03-02 Optimax Holdings Berhad Receives Approval from Ministry of Health to Offer Otorhinolaryngology (Ear, Nose and Throat) Services CI
02-27 Optimax Holdings Berhad Announces Second Interim Single-Tier Dividend on Ordinary Share, Payable 30 March 2026 CI
02-26 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 CI
11-26 Optimax Holdings Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-26 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2025, Payable on 26 December 2025 CI
08/10/25 Hong Leong Investment Bank Starts Optimax Holdings at Buy with 0.96 Ringgit Price Target MT
27/08/25 Optimax Holdings Berhad Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
28/05/25 Optimax Holdings Berhad Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
27/02/25 Optimax Holdings Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 CI
27/02/25 Optimax Holdings Berhad Announces Interim Single-Tier Dividend for the Year Ended 31 December 2024, Payable on 28 March 2025 CI
1 day-0.95%
1 week-0.95%
Current month-0.95%
1 month-1.89%
6 months-10.34%
Current year-9.57%
1 week 0.52
Extreme 0.52
0.54
1 month 0.52
Extreme 0.52
0.54
Current year 0.5
Extreme 0.505
0.64
1 year 0.5
Extreme 0.5
0.72
3 years 0.46
Extreme 0.46
0.74
5 years 0.46
Extreme 0.46
0.84
10 years 0.3
Extreme 0.305
0.94
Manager TitleAgeSince
Chief Executive Officer 37 01/12/2019
Director of Finance/CFO 38 01/09/2018
Chief Operating Officer 37 01/01/2024
Director TitleAgeSince
Director/Board Member 81 01/12/2021
Chairman 65 01/12/2021
Director/Board Member 70 09/08/2018
Date Insider Type Main position Quantity % Market Cap.
06-03Buy

Chairman

97,000 0.0179%
05-29Buy

Chairman

3,000 0.0006%
18/04/25
Sena Healthcare Services Sdn. Bhd.
BuyCompany 674,000 0.1241%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-0.95%+1.96%-26.76% 69.84M
+2.20%+0.85%+56.46%+50.83% 130B
+1.45%+8.52%+11.64%+45.15% 92.52B
+0.49%+8.61%+2.31%+76.18% 27.78B
-0.50%+0.20%+22.08%+52.79% 23.63B
-0.55%+2.61%-19.52%-24.56% 20.29B
+1.28%+11.62%+20.64%+160.83% 17.76B
-0.59%+5.32%+64.07%+125.54% 15.13B
-0.49%+0.35%+1.75%+10.08% 14.9B
+2.67%+6.79%-11.79%-1.38% 12.63B
Average +0.50%+4.47%+14.96%+46.87% 35.5B
Weighted average by Cap. +1.27%+4.42%+27.71%+52.26%

Financials

2026 *2027 *
Net sales 152M 37.32M 32.66M 30.1M 27.9M 52.95M 3.54B 53.81M 361M 140M 1.75B 140M 137M 6.04B 157M 38.67M 33.84M 31.18M 28.9M 54.87M 3.67B 55.75M 374M 145M 1.81B 145M 142M 6.26B
Net income 15.65M 3.85M 3.37M 3.1M 2.88M 5.46M 365M 5.55M 37.19M 14.46M 180M 14.44M 14.13M 623M 17.6M 4.32M 3.78M 3.49M 3.23M 6.14M 410M 6.24M 41.82M 16.26M 203M 16.24M 15.89M 700M
Net Debt -3.1M -762K -667K -614K -569K -1.08M -72.29M -1.1M -7.37M -2.86M -35.68M -2.86M -2.8M -123M -12.4M -3.05M -2.67M -2.46M -2.28M -4.32M -289M -4.39M -29.46M -11.46M -143M -11.44M -11.19M -493M
Logo Optimax Holdings
Optimax Holdings Berhad is a Malaysia-based investment holding company offering eye specialist services. It has approximately seven satellite clinics/centers, 13 ambulatory care centers, one specialist hospital, and 288 staff/professional doctors. Its geographical segments include North Malaysia, Central Malaysia, South Malaysia, East Malaysia, and Cambodia. Its services are categorized into Refractive Surgery, Treatment of Eye Diseases and Disorders, Consultation and Dispensary Services, Oculoplastic Surgery, Plastic Surgery, and Aesthetic Services. Refractive Surgery includes laser and implant vision correction procedures. Treatment of Eye Diseases and Disorders includes cataract surgery and other medical interventions. Consultation and Dispensary Services cover doctor consultations and medication dispensing. Oculoplastic Surgery provides functional and cosmetic treatments around the eye. Its additional services include Eye Examinations, Sales of Optical Wear, and Laboratory Tests.
Employees
-
Date Price Change Volume
08/07/26 MYR 0.5200 -0.95% 1,000
07/07/26 MYR 0.5250 0.00% 25,400
06/07/26 MYR 0.5250 0.00% 241,400
03/07/26 MYR 0.5250 -0.94% 62,500
02/07/26 MYR 0.5300 +0.95% 133,400
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
0.5250MYR
Average target price
0.6880MYR
Spread / Average Target
+31.05%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 0222 Stock